Icotec ag, a company focused on spinal tumor implants, earned $30 million in growth financing from MVM Partners, according to a Jan. 24 news release.
The strategic partnership will support Icotec's research and development, the release said. The medtech company is behind the BlackArmor carbon/PEEK products for spinal oncology.
"This partnership marks a pivotal moment for icotec, supporting us to advance our mission of improving patient outcomes by offering a convincing alternative to the 100-year-old material technology of metal implants," Group CEO of Icotec, Roger Stadler, said in the release.